DORRETT BLACK: Open Payments
NPI 1447010780 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,833 in 47 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,261 · 2025 $1,833
Food & beverage: $1,833
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $675 |
| ABBVIE INC. | 24 | $476 |
| E.R. Squibb & Sons, L.L.C. | 4 | $282 |
| Neurocrine BioSciences, Inc. | 2 | $139 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Corium, LLC | 3 | $46 |
| Lundbeck LLC | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, COBENFY, INGREZZA, Auvelity, REXULTI, Azstarys, ARISTADA.
Industry payments across CT — which companies pay providers there.
